Allergy and Immunology, Allergy · Chico, CA
NPI
1205849858
Since 2006
Specialty
Allergy and Immunology, Allergy
Code 207KA0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
145 Mission Ranch Blvd, Suite 110
Chico, CA, 95926
Phone (530) 896-2200
Groups this clinician bills Medicare through
Medicare paid, 2024
$294K
28,944 services
Medicare patients, 2024
735
Average age 74
Drug cost, 2024
$1.1M
3,675 prescriptions
Company payments, 2025
$1,500
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anton R Dotson was code 95004 (test - miscellaneous), 11,173 times for 159 patients. In total Anton R Dotson billed 28,944 services in 40 codes, and Medicare paid $294K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 11,173 | 159 | $2.60 | $29K |
| 95165 Treatment - Miscellaneous | Office | 6,240 | 254 | $10.94 | $68K |
| 95117 Treatment - Miscellaneous | Office | 5,092 | 225 | $8.83 | $45K |
| 95024 Test - Miscellaneous | Office | 2,729 | 121 | $5.96 | $16K |
| 99213 Office E&M - Established | Office | 607 | 517 | $60.93 | $37K |
| 95115 Treatment - Miscellaneous | Office | 357 | 36 | $7.60 | $2,712 |
| 94010 Pulmonary Function Testing | Office | 351 | 293 | $19.15 | $6,722 |
| 96401 Chemotherapy Administration | Office | 328 | 31 | $54.94 | $18K |
| 95012 Pulmonary | Office | 168 | 149 | $13.67 | $2,297 |
| 99214 Office E&M - Established | Office | 165 | 133 | $88.72 | $15K |
| 95018 Test - Miscellaneous | Office | 162 | 15 | $15.51 | $2,512 |
| 31231 Nasal/Sinus Endoscopy | Office | 97 | 93 | $143.17 | $14K |
| 99203 Office E&M - New | Office | 82 | 82 | $74.24 | $6,088 |
| 30100 Other Organ Systems | Office | 81 | 81 | $58.58 | $4,745 |
| 94060 Pulmonary Function Testing | Office | 51 | 51 | $29.88 | $1,524 |
By year: 2022 $943K for 48,919 services; 2023 $930K for 55,951 services; 2024 $294K for 28,944 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anton R Dotson prescribed most often to Medicare patients was Montelukast Sodium, with 1,036 prescriptions and refills. In total Anton R Dotson wrote 3,675 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 1,036 | 2,192 | 257 | $10K |
| Levocetirizine Dihydrochloride Generic | 438 | 823 | 108 | $6,797 |
| Ipratropium Bromide Generic | 359 | 531 | 113 | $14K |
| Azelastine-Fluticasone Azelastine/Fluticasone | 188 | 244 | 52 | $23K |
| Hydroxyzine Hcl Generic | 124 | 191 | 32 | $2,502 |
| Dupixent Syringe Dupilumab | 124 | 129 | 13 | $490K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 117 | 140 | 67 | $4,452 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 108 | 148 | 25 | $88K |
| Fluticasone Propionate Generic | 104 | 231 | 38 | $2,657 |
| Breo Ellipta Fluticasone/Vilanterol | 98 | 182 | 23 | $68K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 98 | 138 | 17 | $85K |
| Famotidine Generic | 72 | 154 | 20 | $911 |
| Azelastine Hcl Generic | 61 | 118 | 25 | $2,010 |
| Arnuity Ellipta Fluticasone Furoate | 54 | 66 | Under 11 | $16K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 51 | 84 | 15 | $8,360 |
Brand drugs: 863 claims; generic drugs: 2,812 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anton R Dotson $1,500 ($1,500 in general payments such as food, travel and fees) from 14 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $703.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 24 | $703 |
| Genzyme Corporation SNY | 10 | $177 |
| Amgen Inc. AMGN | 10 | $145 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $99.99 |
| Ionis Pharmaceuticals, Inc. IONS | 2 | $60.37 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $60.28 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $54.81 |
| GlaxoSmithKline, LLC. GSK | 2 | $52.56 |
| Optinose US, Inc. | 3 | $45.72 |
| Grifols USA, LLC | 2 | $37.63 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.